121 related articles for article (PubMed ID: 11588555)
1. Hepatic granulomas in chronic hepatitis C.
Mert A; Tabak F; Ozaras R; Tahan V; Senturk H; Ozbay G
J Clin Gastroenterol; 2001 Oct; 33(4):342-3. PubMed ID: 11588555
[No Abstract] [Full Text] [Related]
2. Antiviral therapy for chronic hepatitis C.
Sievert W
Aust Fam Physician; 2003 Oct; 32(10):826-32. PubMed ID: 14596080
[No Abstract] [Full Text] [Related]
3. Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.
Jacobson IM; Ahmed F; Russo MW; Lebovics E; Dieterich DT; Esposito SP; Bach N; Klion F; Tobias H; Antignano L; Brown RS; Gabbaizadeh D; Geders J; Levendoglu H
Am J Gastroenterol; 2004 Sep; 99(9):1700-5. PubMed ID: 15330905
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.
Mangia A; Ricci GL; Persico M; Minerva N; Carretta V; Bacca D; Cela M; Piattelli M; Annese M; Maio G; Conte D; Guadagnino V; Pazienza V; Festi D; Spirito F; Andriulli A
J Viral Hepat; 2005 May; 12(3):292-9. PubMed ID: 15850470
[TBL] [Abstract][Full Text] [Related]
6. 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
van Leeuwen DJ; Yee LJ; Langner RG
Am J Gastroenterol; 2002 Feb; 97(2):497-8. PubMed ID: 11866304
[No Abstract] [Full Text] [Related]
7. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4.
Alfaleh FZ; Hadad Q; Khuroo MS; Aljumah A; Algamedi A; Alashgar H; Al-Ahdal MN; Mayet I; Khan MQ; Kessie G
Liver Int; 2004 Dec; 24(6):568-74. PubMed ID: 15566506
[TBL] [Abstract][Full Text] [Related]
8. Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4.
Hasan F; Asker H; Al-Khaldi J; Siddique I; Al-Ajmi M; Owaid S; Varghese R; Al-Nakib B
Am J Gastroenterol; 2004 Sep; 99(9):1733-7. PubMed ID: 15330911
[TBL] [Abstract][Full Text] [Related]
9. Peginterferon and ribavirin in a patient with acute hepatitis C.
Rodríguez-Gómez SJ; de la Serna-Higuera C; Pérez-Villoria A; Martínez-Moreno J; Betancourt-González A; Martín-Arribas MI
Am J Gastroenterol; 2003 Sep; 98(9):2102-3. PubMed ID: 14499798
[No Abstract] [Full Text] [Related]
10. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
Fiel MI; Shukla D; Saraf N; Xu R; Schiano TD
Transpl Infect Dis; 2008 Jun; 10(3):184-9. PubMed ID: 17916116
[TBL] [Abstract][Full Text] [Related]
11. Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.
Teuber G; Berg T; Hoffmann RM; Leifeld L; Lafrenz M; Spengler U; Pape GR; Hopf U; Zeuzem S
Digestion; 2000; 61(2):90-7. PubMed ID: 10705172
[TBL] [Abstract][Full Text] [Related]
12. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon and ribavirin in haemodialysis patients.
Bruchfeld A; Lindahl K; Reichard O; Carlsson T; Schvarcz R
Nephrol Dial Transplant; 2006 May; 21(5):1444-5; author reply 1445-6. PubMed ID: 16517569
[No Abstract] [Full Text] [Related]
14. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response.
Petrenkiene V; Gudinaviciene I; Jonaitis L; Kupcinskas L
Medicina (Kaunas); 2004; 40(6):538-46. PubMed ID: 15208476
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
Yu ML; Dai CY; Lin ZY; Lee LP; Hou NJ; Hsieh MY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
Liver Int; 2006 Feb; 26(1):73-81. PubMed ID: 16420512
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
Chuang WL; Dai CY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Yu ML; Chang WY
Liver Int; 2004 Dec; 24(6):595-602. PubMed ID: 15566510
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of a 4- vs 12-week daily interferon dose regimen combined with ribavirin in treatment of patients with chronic hepatitis C.
Sarin SK; Goyal A; Kumar S; Guptan RC; Hashmi AZ; Sakhuja P; Malhotra V
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):42-8. PubMed ID: 14969836
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.
Baker DE
Rev Gastroenterol Disord; 2003; 3(2):93-109. PubMed ID: 12776006
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characterization and peculiarities of the clinical course of low-activity hepatitis C].
Karpov SIu; Krel' PE
Klin Med (Mosk); 2005; 83(1):14-9. PubMed ID: 15759484
[No Abstract] [Full Text] [Related]
20. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
